KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.47 $1.47 Thursday, 10th Nov 2022 EPZM stock ended at $1.47. During the day the stock fluctuated 0% from a day low at $1.47 to a day high of $1.47.
90 days $1.47 $1.47
52 weeks $0.411 $4.88

Historical Epizyme prices

Date Open High Low Close Volume
Nov 19, 2019 $15.50 $16.18 $15.40 $16.04 790 064
Nov 18, 2019 $15.40 $15.50 $15.21 $15.42 748 040
Nov 15, 2019 $15.38 $15.49 $15.11 $15.36 248 977
Nov 14, 2019 $15.22 $15.43 $15.00 $15.26 338 585
Nov 13, 2019 $14.83 $15.31 $14.70 $15.26 275 036
Nov 12, 2019 $14.87 $15.12 $14.71 $15.03 450 810
Nov 11, 2019 $15.09 $15.25 $14.51 $14.86 515 305
Nov 08, 2019 $14.39 $15.20 $13.95 $15.18 722 493
Nov 07, 2019 $13.61 $14.42 $13.61 $14.40 748 354
Nov 06, 2019 $14.71 $15.12 $13.39 $13.51 1 175 626
Nov 05, 2019 $13.08 $14.76 $13.00 $14.76 1 823 431
Nov 04, 2019 $12.41 $13.30 $12.26 $12.46 1 346 178
Nov 01, 2019 $11.63 $12.04 $11.54 $11.85 1 094 553
Oct 31, 2019 $11.66 $11.85 $11.30 $11.51 1 121 363
Oct 30, 2019 $10.74 $11.59 $10.70 $11.56 1 903 089
Oct 29, 2019 $11.10 $11.15 $10.51 $10.55 319 612
Oct 28, 2019 $10.61 $11.24 $10.61 $11.06 294 507
Oct 25, 2019 $10.98 $11.14 $10.54 $10.60 555 679
Oct 24, 2019 $10.92 $11.10 $10.73 $11.00 350 912
Oct 23, 2019 $10.80 $10.92 $10.71 $10.85 236 989
Oct 22, 2019 $10.85 $11.04 $10.74 $10.84 309 401
Oct 21, 2019 $10.47 $10.76 $10.37 $10.74 313 416
Oct 18, 2019 $10.40 $10.55 $10.29 $10.34 285 172
Oct 17, 2019 $10.32 $10.57 $10.31 $10.47 281 140
Oct 16, 2019 $10.27 $10.55 $10.25 $10.27 236 234
Click to get the best stock tips daily for free!

About Epizyme

Epizyme Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in pa... EPZM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT